Literature DB >> 5062828

Methyldopahydrazine as an adjunct to L-dopa therapy in parkinsonism.

T N Chase, A M Watanabe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5062828     DOI: 10.1212/wnl.22.4.384

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  6 in total

1.  Editorial: Dopa decarboxylase inhibitors.

Authors: 
Journal:  Br Med J       Date:  1974-11-02

Review 2.  Clinical pharmacokinetics of anti-parkinsonian drugs.

Authors:  J M Cedarbaum
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

Review 3.  Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1976       Impact factor: 9.546

4.  The emetic action of L-dopa and its effect on the swallowing reflex in the cat.

Authors:  D Bieger; A Weerasuriya; C H Hockman
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

5.  [HGH secretion after oral application of L-dopa and L-carbidopa (author's transl)].

Authors:  W Schönberger; R Ziegler; B Brodt; W Grimm
Journal:  Eur J Pediatr       Date:  1976-06-08       Impact factor: 3.183

6.  Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study.

Authors:  Roberto Cilia; Janeth Laguna; Erica Cassani; Emanuele Cereda; Nicolò G Pozzi; Ioannis U Isaias; Manuela Contin; Michela Barichella; Gianni Pezzoli
Journal:  Neurology       Date:  2017-07-05       Impact factor: 9.910

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.